HAI2023 returned to in-person format in Miami - and we were there!
Program Committee
Gil Rabinovici & Renaud La Joie
Presentations
Daniel Schonhaut
Large-sample, longitudinal tau-PET in sporadic early-onset Alzheimer’s disease: findings from the LEADS Consortium
Julien Lagarde
Heterogeneity of amyloid-PET-negative patients with a clinical diagnosis of sporadic early-onset AD: an FDG-PET study in the LEADS cohort
Renaud La Joie
Quantitative analysis of amyloid-PET from real-world practice: lessons learned from processing the IDEAS dataset
Posters
Jhony Mejia Perez
[18F]PI-2620 tau-PET binding patterns in American football players with suspected Chronic Traumatic Encephalopathy
David Soleimani-Meigooni
Synaptic loss in relapsing and progressive multiple sclerosis: an in vivo exploratory study using SV2A-PET
Charles Windon
Amyloid PET scan reader agreement in IDEAS: expert readers vs local clinician readers
Renaud La Joie
"Treatment Related Amyloid Clearance" (TRAC): a framework to characterize a new biomarker state in the era of anti-amyloid therapies
